Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
How Abbott's Largest Segment Is Preparing for the Next Growth Phase
10:21am, Monday, 29'th Jun 2026
ABT's Medical Devices unit builds on strong growth with new diabetes, heart rhythm and electrophysiology advances ahead of Q2 2026.
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
09:17pm, Sunday, 28'th Jun 2026
The U.S. Justice Department closed a criminal probe into Abbott Laboratories over how it managed a baby formula facility where potentially deadly bacteria were discovered and s
The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case.
09:00pm, Sunday, 28'th Jun 2026
WASHINGTON—The Justice Department spent years investigating Abbott Laboratories ABT 0.94%increase; up pointing triangle over how it managed a baby formula facility where potentially deadly bacteria
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000
10:05am, Sunday, 28'th Jun 2026
During times of market turmoil, investors cycle back into defensive, dividend-focused names like Abbott Laboratories. Besides Dividend King status and a moderately high dividend yield, this diversifie
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?
09:36am, Friday, 26'th Jun 2026
DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to watch now.
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy
02:20pm, Thursday, 25'th Jun 2026
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) at $90.53 is a Buy.
Abbott hosts conference call for second-quarter earnings
09:00am, Thursday, 25'th Jun 2026
ABBOTT PARK, Ill., June 25, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2026 financial results on Thursday, July 16, before the market opens.
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy
01:36pm, Wednesday, 24'th Jun 2026
Abbott Laboratories (NYSE:ABT | ABT Price Prediction) is a stock with characteristics suited to multi-decade ownership, because its four-segment healthcare engine, 54 consecutive years of dividend inc
MiniMed Launches Abbott's Instinct Sensors Across European Markets
01:21pm, Wednesday, 24'th Jun 2026
MMED expands its European diabetes tech reach with Abbott sensor integration, boosting user flexibility and its connected care ecosystem.
How Are Emerging Markets Supporting Abbott's EPD Momentum?
09:56am, Wednesday, 24'th Jun 2026
ABT's Emerging Markets drive EPD growth, with strong branded generics demand, biosimilar expansion and new approvals boosting momentum.
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
08:30am, Wednesday, 24'th Jun 2026
ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ -- ALZpath Inc., the leader in blo
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test
07:36am, Wednesday, 24'th Jun 2026
ALZpath said on Wednesday it had signed a global licensing agreement with Abbott Laboratories to help advance blood-based testing for Alzheimer's disease, as companies race to offer easier-to-us
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 23'rd Jun 2026
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Monster Stocks to Hold for the Next 10 Years
06:05am, Tuesday, 23'rd Jun 2026
These players sell market-leading products and are tackling growth industries. Holding for several years, rather than a short period, allows investors to fully benefit from each company's story.
Despite optimism about parenthood, unrealistic online portrayals are adding pressure for today's young parents Through the new "Love Without Measure" initiative, Similac is standing with parents in pr
